Total Payments
$15,264
2024 Payments
$4,133
Companies
31
Transactions
839
Medicare Patients
9,060
Medicare Billing
$523,604
Payment Breakdown by Category
Food & Beverage$14,890 (97.5%)
Education$290.34 (1.9%)
Travel$84.25 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,890 | 833 | 97.5% |
| Education | $290.34 | 5 | 1.9% |
| Travel and Lodging | $84.25 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,650 | 204 | $0 (2024) |
| Janssen Biotech, Inc. | $3,095 | 148 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,177 | 63 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $869.06 | 49 | $0 (2024) |
| PFIZER INC. | $803.09 | 52 | $0 (2024) |
| GENZYME CORPORATION | $686.44 | 30 | $0 (2024) |
| UCB, Inc. | $652.87 | 43 | $0 (2024) |
| Incyte Corporation | $521.90 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $506.98 | 30 | $0 (2024) |
| Amgen Inc. | $480.52 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,133 | 241 | Janssen Biotech, Inc. ($947.31) |
| 2023 | $4,524 | 257 | Janssen Biotech, Inc. ($1,077) |
| 2022 | $4,117 | 201 | ABBVIE INC. ($1,158) |
| 2021 | $2,490 | 140 | AbbVie Inc. ($704.98) |
All Payment Transactions
839 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: Inflammation & Immunology | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.44 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.73 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $43.33 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.59 | General |
| Category: Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.16 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,175 | 4,154 | $767,479 | $134,235 |
| 2022 | 15 | 2,577 | 5,077 | $851,837 | $151,907 |
| 2021 | 15 | 2,179 | 4,389 | $699,090 | $130,289 |
| 2020 | 17 | 2,129 | 3,937 | $466,764 | $107,172 |
Total Patients
9,060
Total Services
17,557
Medicare Billing
$523,604
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 582 | 853 | $253,341 | $44,072 | 17.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 417 | 594 | $132,462 | $21,206 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 198 | $83,160 | $14,395 | 17.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 198 | 225 | $76,050 | $14,121 | 18.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 212 | 271 | $50,406 | $9,272 | 18.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 279 | 1,429 | $32,867 | $6,112 | 18.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 12 | 18 | $22,950 | $5,439 | 23.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 46 | $27,324 | $4,957 | 18.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 32 | 45 | $25,290 | $4,901 | 19.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $20,664 | $3,102 | 15.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 20 | 23 | $8,694 | $1,574 | 18.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 32 | 37 | $6,216 | $1,296 | 20.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 13 | $6,396 | $1,109 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,564 | $789.15 | 12.0% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 12 | $3,852 | $722.70 | 18.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 59 | $2,773 | $557.59 | 20.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 13 | $2,470 | $405.32 | 16.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 51 | 250 | $6,000 | $205.27 | 3.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 587 | 832 | $245,440 | $43,517 | 17.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 564 | 780 | $172,380 | $28,642 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 248 | $103,168 | $19,255 | 18.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 214 | 248 | $83,824 | $16,054 | 19.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 310 | 409 | $75,256 | $12,683 | 16.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 390 | 2,066 | $47,518 | $9,066 | 19.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 48 | 65 | $36,010 | $7,027 | 19.5% |
About Rachel Miller, PAC
Rachel Miller, PAC is a Physician Assistant healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013956291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Miller, PAC has received a total of $15,264 in payments from pharmaceutical and medical device companies, with $4,133 received in 2024. These payments were reported across 839 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($14,890).
As a Medicare-enrolled provider, Miller has provided services to 9,060 Medicare beneficiaries, totaling 17,557 services with total Medicare billing of $523,604. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Austin, TX
- Active Since 06/05/2006
- Last Updated 08/08/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1013956291
Products in Payments
- TREMFYA (Drug) $2,968
- SKYRIZI (Biological) $1,725
- RINVOQ (Biological) $1,489
- EUCRISA (Drug) $610.20
- DUPIXENT (Biological) $599.91
- OPZELURA (Drug) $521.90
- Winlevi (Drug) $501.92
- Sotyktu (Drug) $500.75
- Otezla (Drug) $480.52
- REMICADE (Biological) $472.44
- COSENTYX (Drug) $465.38
- VTAMA (Drug) $418.89
- Cimzia (Drug) $410.09
- COSENTYX (Biological) $345.72
- HUMIRA (Biological) $305.64
- ILUMYA (Biological) $290.42
- Bimzelx (Biological) $242.78
- TALTZ (Drug) $226.65
- CIBINQO (Drug) $192.89
- ENSTILAR (Drug) $123.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Austin
Ms. Selina Santos, Pa-C, PA-C
Physician Assistant — Payments: $465,204
Physician Assistant $465,204
Mr. Stephen Ingram, Pa, PA
Physician Assistant — Payments: $151,100
Physician Assistant $151,100
Mrs. Ashlea Lucas, Pa-C, PA-C
Physician Assistant — Payments: $21,745
Physician Assistant $21,745
Mrs. Alexis Holder, Pa, PA
Physician Assistant — Payments: $14,510
Physician Assistant $14,510
Samantha Eshelman
Physician Assistant — Payments: $14,505
Physician Assistant $14,505
Elizabeth Gorrick, Pa-C, PA-C
Physician Assistant — Payments: $13,921
Physician Assistant $13,921